Host-iron assimilation: pathogenesis and novel therapies of mucormycosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Host-iron assimilation: pathogenesis and novel therapies of mucormycosis
Authors
Keywords
-
Journal
MYCOSES
Volume 57, Issue -, Pages 13-17
Publisher
Wiley
Online
2014-09-02
DOI
10.1111/myc.12232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CotH3 mediates fungal invasion of host cells during mucormycosis
- (2013) Teclegiorgis Gebremariam et al. JOURNAL OF CLINICAL INVESTIGATION
- Mucormycosis in a Patient with Acute Myeloid Leukemia Successfully Treated with Liposomal Amphotericin B Associated with Deferasirox and Hyperbaric Oxygen
- (2013) Eduardo Flavio Oliveira Ribeiro et al. MYCOPATHOLOGIA
- Meeting the Challenges of an Emerging Pathogen: The Henry Schueler 41&9 Foundation International Forum on Mucormycosis
- (2012) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Invasive Mold Infections Following Combat-related Injuries
- (2012) T. Warkentien et al. CLINICAL INFECTIOUS DISEASES
- Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011
- (2012) Robyn Neblett Fanfair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
- (2011) A. Skiada et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
- (2011) M. Z. R. Gomes et al. CLINICAL MICROBIOLOGY REVIEWS
- Host cell invasion in mucormycosis: role of iron
- (2011) Ashraf S Ibrahim CURRENT OPINION IN MICROBIOLOGY
- Deferasirox in mucormycosis: hopefully, not defeated
- (2011) R. Soman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Deferasirox as adjunctive therapy for mucormycosis
- (2011) J. P. Donnelly et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial
- (2011) Brad Spellberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
- (2010) Mingfu Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Apophysomyces elegans: Epidemiology, Amplified Fragment Length Polymorphism Typing, andIn VitroAntifungal Susceptibility Pattern
- (2010) A. Chakrabarti et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis
- (2010) Ashraf S. Ibrahim et al. MOLECULAR MICROBIOLOGY
- Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
- (2009) B. Spellberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fatal Actinomucor elegans var. kuwaitiensis Infection following Combat Trauma
- (2009) C. C. Tully et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Invasive zygomycosis in India: experience in a tertiary care hospital
- (2009) A Chakrabarti et al. POSTGRADUATE MEDICAL JOURNAL
- Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis
- (2008) G. Chamilos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now